SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-019876
Filing Date
2022-05-12
Accepted
2022-05-12 16:18:40
Documents
62
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q achv-10q_20220331.htm   iXBRL 10-Q 1857186
2 EX-31.1 achv-ex311_7.htm EX-31.1 9064
3 EX-32.1 achv-ex321_6.htm EX-32.1 4874
  Complete submission text file 0001564590-22-019876.txt   6575029

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA achv-20220331.xsd EX-101.SCH 50460
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE achv-20220331_cal.xml EX-101.CAL 37408
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE achv-20220331_def.xml EX-101.DEF 179475
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE achv-20220331_lab.xml EX-101.LAB 371943
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE achv-20220331_pre.xml EX-101.PRE 289746
56 EXTRACTED XBRL INSTANCE DOCUMENT achv-10q_20220331_htm.xml XML 1079021
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 033-80623 | Film No.: 22918080
SIC: 2835 In Vitro & In Vivo Diagnostic Substances